US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Directa Plus PLC (EM) (DTPKF) 銘柄情報

Directa Plus PLC (EM) (DTPKF)

0.0203

0.00

(0.00%)

終了 6月27日 5:00AM

Directa Plus PLC (EM) (DTPKF) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.0203

( - )

買値

0.00

売値

0.00

出来高

-

0.00 日の範囲 0.00

0.006 52 週間の範囲 0.50

時価総額

前日終値

0.0203

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 1,795

発行済株式数

104,418,755

配当利回り

PER

-0.39

1 株当たり利益 (EPS)

-0.04

歳入

7.17M

純利益

-4.32M

Directa Plus Plc manufactures and sells graphene-based products for industrial and commercial applications in Italy, Romania, and internationally. The company operates through Textiles, Environmental Remediation, and Others segments. It also engages in the business of waste management and decontamin... Directa Plus Plc manufactures and sells graphene-based products for industrial and commercial applications in Italy, Romania, and internationally. The company operates through Textiles, Environmental Remediation, and Others segments. It also engages in the business of waste management and decontamination services, as well as provides textile membranes, including graphene-based technical and high-performance membranes. The company offers its products under the G+ brand name. Its products are used in environment, textile, composites, elastomers, battery, and paints applications. Directa Plus Plc was incorporated in 2003 and is based in Lomazzo, Italy. 詳細を表示

セクター

Materials

業界

Chemicals

ウェブサイト

www.directa-plus.com

本社

Lomazzo, Italy

設立

2026

Directa Plus PLC (EM) is listed in the Materials sector of the その他OTC with ticker DTPKF. The last closing price for Directa Plus (EM) was US$0.02. Over the last year, Directa Plus (EM) shares have traded in a share price range of US$ 0.006 to US$ 0.50.

Directa Plus (EM) currently has 104,418,755 shares in issue. The market capitalisation of Directa Plus (EM) is US$2.12 million. Directa Plus (EM) has a price to earnings ratio (PE ratio) of -0.39.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0.0203	0.0203	0.0203	750	0.0203	CS
26	-0.0997	-83.0833333333	0.12	0.5	0.006	9802	0.13847584	CS
52	-0.1487	-87.9881656805	0.169	0.5	0.006	9529	0.13638018	CS
156	-0.7797	-97.4625	0.8	0.8	0.006	5781	0.15990996	CS
260	-1.6897	-98.8128654971	1.71	2.4	0.006	3764	0.32756557	CS

DTPKF - Frequently Asked Questions (FAQ)

What is the current Directa Plus PLC (EM) share price?

The current share price of Directa Plus PLC (EM) is US$ 0.0203

How many Directa Plus PLC (EM) shares are in issue?

Directa Plus PLC (EM) has 104,418,755 shares in issue

What is the market cap of Directa Plus PLC (EM)?

The market capitalisation of Directa Plus PLC (EM) is USD 2.12M

What is the 1 year trading range for Directa Plus PLC (EM) share price?

Directa Plus PLC (EM) has traded in the range of US$ 0.006 to US$ 0.50 during the past year

What is the PE ratio of Directa Plus PLC (EM)?

The price to earnings ratio of Directa Plus PLC (EM) is -0.39

What is the cash to sales ratio of Directa Plus PLC (EM)?

The cash to sales ratio of Directa Plus PLC (EM) is 0.25

What is the registered address of Directa Plus PLC (EM)?

The registered address for Directa Plus PLC (EM) is ComoNExT Science Park, Lomazzo, Como, 22074

What is the Directa Plus PLC (EM) website address?

The website address for Directa Plus PLC (EM) is www.directa-plus.com

Which industry sector does Directa Plus PLC (EM) operate in?

Directa Plus PLC (EM) operates in the Chemicals sector

Dodger1

Dodger1 17分前

Personal freedoms...BTC?

Dodger1

Dodger1 19分前

Why everything hinge on BTC?

Dodger1

Dodger1 25分前

The premise, BTC, Hungry..nice.but.dated

Dodger1

Dodger1 28分前

Perhaps 911 extends personal rights...BTC?

mdb1

How many promised milestones has this company missed in a row?????!!!!!???

Dodger1

Dodger1 32分前

Realism 🫡 Data wants 911 more and more

janice shell

janice shell 36分前

Much of it looks tasty...

BigB111

BigB111 44分前

When you're 80 and your life is nearly over sometimes being grumpy and hanging on to a grudge is all you have.

BigB111

BigB111 46分前

Their legacy stuff is worthless and has zero use. That's not where their value is or what the lawsuit is about. This lawsuit just needs to be gone so they can move forward. Plain & simple $TMMI

BigB111

BigB111 49分前

You would think if Panik was to be successful in something other than teeth it would have happened before he was 80. Definition of a grumpy old man that has zero drive in life left so why not just make everyone else's life miserable. He texts like a 14 year old teenage girl. What a sad old man he is

sentiment_stocks

sentiment_stocks 59分前

I believe GZ is probably right.

Mr. Dragon

Mr. Dragon 1時間前

MMM...his name is mud now after he took to twits and ripped on everyone for screaming about the manipulation. He said we were "babies" and we should "shut up and put your big boy pants on."

He's full of siht as he's been predicting "NIO to $650" for how many years now?
He ha

getsome140backagain

getsome140backagain 1時間前

Judging by past filings that is what we should be looking for on Wednesday. IF they stick to when they have put out their filings in the past. New company though so who knows. IF they do put one out hopefully it explains what the eff is going on. I’m not holding my breath on that though, I’m neutral

GreenOverGreed

GreenOverGreed 1時間前

https://x.com/greenovergreed1/status/2070654290847572103?s=46&t=u_wvMla03rgmkeLnpx2Wxg

Just give me $1.50

Just give me $1.50 1時間前

Elite will be acquired, merged, or on the Nasdaq by THIS coming Tuesday AS STATED by Rat.

Y'all ready?

Just give me $1.50

Just give me $1.50 1時間前

LMAO!!!!!!!!!!!!!!!!!!!!!!!!!!!

HGiLS -- "If an M&A transaction is not finalized by the end of 2026 , what is the exact operational or share price trigger point that will cause management to pivot entirely toward execution of a structural NASDAQ uplisting?"
___________________

Just give me $1.50

Just give me $1.50 2時間前

Looking forward to it.

Press release Monday or Tuesday.

Rat: "We received approval for Ropinirole, and that's another product that WE WILL be launching in Q2 of 2026 ."

Just give me $1.50

Just give me $1.50 2時間前

........but there will be no offers until The Mikah Scam is resolved.

It's the only thing holding up the entire process, which is why 100 PERCENT of this board is submitting one or more questions about it for next week's Mikah Conference Call.

They can’t accept an offer

Just give me $1.50

Just give me $1.50 2時間前

Doesn't matter.

Only thing that matters is the price.

Packet in the mail for less than $1.50 gets immediately thrown in the trash 🗑️.

Would love a email THE PACKET IS IN THE MAIL !

Just give me $1.50

Just give me $1.50 2時間前

Can they afford us?

If it's a cash buyout, what bank would be willing to lend them $1.8 billion (or more)?

They already have $2.4 billion in debt.

Amneal has made some recent takeovers and its website indicates it is prowling for more. Fingers and toes cr

gitreal

gitreal 2時間前

Express1, you were correct, that link you provided is to the Schappert report. My virus blocker has not allowed me to access that link in their PR, or their website, calls it an unsafe site. I was relying on a couple pages sent by someone, and it appeared to be the same language as in the PR, but

Just give me $1.50

Just give me $1.50 2時間前

REMINDER!!!!!

Get your MIKAH SCAM questions submitted by 7:00 PM EDT, Monday, June 29, 2026.

Questions: dianne@elitepharma.com

Repeal the Mikah Tax -- To be paid by all shareholders at buyout
1. Cost of Second Tier Suitors
2. Cost of Secret

skitahoe

skitahoe 2時間前

The last time we had a similar presentation, Dr. Liau was supposed to be presenting at NYAS, we were up dramatically before the presentation, but we all know what happened when she got Covid19 in England and we got killed by AdamF, etc.

How do people feel about getting some gain befor

go seek

go seek 2時間前

$15 next week…

starric

starric 2時間前

What caught my attention was this section on cancer immunotherapy:
“The Committee is aware of emerging personalized dendritic and other promising cell-based therapeutic platforms… and encourages expanded support for translational, manufacturing, and clinical evaluation efforts that advance th

Directa Plus (EM)

Bicara Therapeutics

Victoria's Secret

Regeneron Pharmaceuticals

State Street Health Care...

Purpose Bitcoin ETF

ProShares Nasdaq 100 Dyn...

SavvyShort -2X NVDA ETF

PSP Swiss Property

Northcliff Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。